Platelet-derived endothelial cell growth factor/thymidine phosphorylase immunohistochemical expression in lymphoid tissue and lymphoid malignancies
- 1 October 1997
- journal article
- Published by Elsevier in Human Pathology
- Vol. 28 (10) , 1146-1151
- https://doi.org/10.1016/s0046-8177(97)90252-5
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Platelet‐derived endothelial cell growth factor/thymidine phosphorylase expression in normal tissues: An immunohistochemical studyThe Journal of Pathology, 1995
- Expression of platelet‐derived endothelial cell growth factor/thymidine phosphorylase in human breast cancerInternational Journal of Cancer, 1995
- Association of ovarian Malignancy With Expression of Paltelet-Derived Endothelial Cell Growth FactorJNCI Journal of the National Cancer Institute, 1994
- Thymidine phosphorylase activity of platelet‐derived endothelial cell growth factor is responsible for endothelial cell mitogenicityEuropean Journal of Biochemistry, 1993
- Cytokines induce thymidine phosphorylase expression in tumor cells and make them more susceptible to 5?-deoxy-5-fluorouridineCancer Chemotherapy and Pharmacology, 1993
- Expression of platelet-derived endothelial cell growth factor in Escherichia coli and confirmation of its thymidine phosphorylase activityBiochemistry, 1992
- Platelet-derived endothelial cell growth factor has thymidine phosphorylase activityBiochemical and Biophysical Research Communications, 1992
- Angiogenic factorNature, 1992
- Purification and tissue distribution of human thymidine phosphorylase; high expression in lymphocytes, reticulocytes and tumorsBiochimica et Biophysica Acta (BBA) - General Subjects, 1990
- Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factorNature, 1989